Coloplast CEO Kristian Villumsen steps down from his CEO position as of today. The Board of Directors has asked Lars Rasmussen to step in as interim CEO. As the company is entering into a new strategy ...

Coloplast launches offering to raise around DKK 9 billion through issue of new B shares in a directed issue and private placement Coloplast A/S (“Coloplast”) has resolved to launch an offering (the ...

"We are excited to offer Titan Prime IPP, a clinically proven solution that helps men suffering from severe erectile dysfunction take back control of their intimate lives and relationships”, says ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The new intermittent catheter Luja™ addresses important risk factors for urinary tract infections, a significant burden for people using intermittent catheters as well as healthcare systems as a whole ...

COPENHAGEN, July 7 (Reuters) - Coloplast (COLOb.CO), opens new tab has agreed to buy Iceland-based Kerecis, a biologic wound care firm that uses fish skin to develop tissue-transplant products, for up ...

Though foreign-exchange headwinds have nagged at Coloplast COLO B, underlying demand remains robust and revenue growth remains on track to meet our full-year projections. We’re holding steady on our ...

The new transanal irrigation device is designed to help people facing defecation issues or stool leakage. It is estimated that 10-15% of the world’s population are affected by chronic constipation1 ...

Organic growth is now expected to be around 7% in constant currencies, from previously 8-9%. The revised organic growth guidance is based on the following updated assumptions: Interventional Urology ...

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

In connection with the publication of Coloplast’s interim financial results for 9M 2024/25, to be released same day in the morning around 07.30h CEST, Coloplast will host a conference call to present ...